Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Shen Lian Biomedical OCF Yield %?
Shanghai Shen Lian BiomedicalSHSE:688098 -1.43%69 OCF Yield % is 0.63 as of Jul. 21, 2026, which is 47% below its 10-year median of 1.19. GuruFocus rates SHSE:688098 with a GF Score™ of 69/100 and a GF Value™ of ¥5.86 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,410 Biotechnology companies, Shanghai Shen Lian Biomedical ranks better than 80.14% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Shanghai Shen Lian Biomedical OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shanghai Shen Lian Biomedical OCF Yield % Related Terms
Shanghai Shen Lian Biomedical OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688098 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Shanghai Shen Lian Biomedical's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shen Lian Biomedical OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Shen Lian Biomedical's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai Shen Lian Biomedical's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shen Lian Biomedical (SHSE:688098) has a OCF Yield % of 0.63 as of Jul. 21, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai Shen Lian Biomedical and its competitors. This is 47% below median its historical median of 1.19. According to the industry distribution chart, Shanghai Shen Lian Biomedical ranks #280 out of 1410 companies in the Biotechnology industry, placing it in the top 19.9%.
Is Shanghai Shen Lian Biomedical's OCF Yield % too high?
Shanghai Shen Lian Biomedical's current OCF Yield % of 0.63 is 47% below median its 10-year median of 1.19. Based on the distribution chart, Shanghai Shen Lian Biomedical ranks #280 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Shen Lian Biomedical has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shen Lian Biomedical's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Shen Lian Biomedical ranks #280 out of 1410 companies for OCF Yield %. This places Shanghai Shen Lian Biomedical in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai Shen Lian Biomedical and its competitors. Shanghai Shen Lian Biomedical's current OCF Yield % is 0.63, which is 47% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shen Lian Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical (SHSE:688098) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥8.28 — trading 41.3% above its estimated fair value. The current OCF Yield % is 0.63, which is 47% below median its 10-year median of 1.19. Shanghai Shen Lian Biomedical's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Shanghai Shen Lian Biomedical (SHSE:688098), the current OCF Yield % is 0.63 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shen Lian Biomedical (SHSE:688098) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical stock appears to be overvalued.
The current stock price of ¥8.28 is trading 41.3% above its estimated GF Value™ of ¥5.86.
GuruFocus considers Shanghai Shen Lian Biomedical to be Significantly Overvalued.
Key valuation signals for SHSE:688098:
OCF Yield %: 0.63 (47% below median its 10-year median of 1.19)
GF Value™: ¥5.86 vs. price of ¥8.28 (41.3% above fair value)
No single metric tells the full story. See the SHSE:688098 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shen Lian Biomedical Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688098 has been successfully added to your 
